MedPath

Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects

Phase 1
Conditions
Pulmonary Diffusing Capacity
Registration Number
NCT00315965
Lead Sponsor
University Hospital Tuebingen
Brief Summary

Using a rapidly responding nitric oxide analyzer in a new developed modular lung-function-setup we are going to measure steady-state NO diffusing capacity in 107 healthy subjects (age 6-45 years). The results will be compared to those measured by using carbon monoxide single-breath estimates. We like to show that the new method is sufficient to measure exactly lung diffusion capacity in this collective.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
107
Inclusion Criteria
  • Healthy volunteers
  • Lung function testing possible
  • Written consent
Exclusion Criteria
  • Pulmonary, neuromuscular, cardiovascular, endocrinological illness
  • Pregnancy
  • Abuse of nicotine, alcohol, drugs during the last two years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
TLCOsb
TLNOss
Secondary Outcome Measures
NameTimeMethod
Breathing frequency
tidal volume
functional residual capacity
airway resistance
lung clearance index
forced expiratory volume in one second
vital capacity
total lung capacity

Trial Locations

Locations (1)

University children´s hospital

🇩🇪

Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath